Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases

Published:2021-10 Issue: Volume:55 Page:103189
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Lotan Itay,Romanow Gabriela,Levy Michael

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference44 articles.

1. COVID-19 and emerging spinal cord complications: A systematic review;Mondal;Mult. Scler. Relat. Disord.,2021

2. COVID-19 mRNA Vaccines (Pfizer-BioNTech and Moderna) and MS,2021

3. COVID-19 Vaccination Guidance for People with MS,2021

4. COVID-19 Vaccine Guidance for People Living with MS,2021

5. Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the USA,2021

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders;Vaccine;2024-10

2. Central nervous system manifestations following vaccination against COVID-19;Brain, Behavior, & Immunity - Health;2024-07

3. Clinical Research into Central Nervous System Inflammatory Demyelinating Diseases Related to COVID-19 Vaccines;Diseases;2024-03-20

4. Occurrence and Risk Factors of Relapse Activity after Vaccination against COVID-19 in People with Multiple Sclerosis: 1-Year Follow-Up Results from a Nationwide Longitudinal Observational Study;Vaccines;2023-12-16

5. Short-term safety of inactivated SARS-Cov-2 vaccines in Chinese patients with central nervous system inflammatory demyelinating diseases;Vaccine: X;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3